Wealth Alliance’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Wealth Alliance’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$441K	Buy	2,786 +76	+3%	+$10.3K	0.04%	344
2026 Q1	$346K	Hold	2,710	–	–	0.03%	391
2025 Q4	$330K	Buy	2,710 +6	+0.2%	+$688	0.03%	408
2025 Q3	$271K	Sell	2,704 -1,001	-27%	-$90.2K	0.03%	449
2025 Q2	$307K	Buy	3,705 +258	+7%	+$20.6K	0.03%	401
2025 Q1	$280K	Sell	3,447 -636	-16%	-$56.8K	0.03%	408
2024 Q4	$368K	Buy	4,083 +173	+4%	+$16.8K	0.04%	320
2024 Q3	$386K	Buy	3,910 +50	+1%	+$4.91K	0.05%	337
2024 Q2	$358K	Sell	3,860 -181	-4%	-$16.2K	0.05%	331
2024 Q1	$383K	Buy	4,041 +1,793	+80%	+$166K	0.05%	331
2023 Q4	$201K	Sell	2,248 -2,578	-53%	-$191K	0.03%	489
2023 Q3	$352K	Sell	4,826 -326	-6%	-$26K	0.06%	307
2023 Q2	$429K	Sell	5,152 -241	-4%	-$20.2K	0.06%	279
2023 Q1	$411K	Sell	5,393 -56	-1%	-$4.65K	0.07%	279
2022 Q4	$452K	Buy	5,449 +225	+4%	+$18.2K	0.08%	250
2022 Q3	$414K	Buy	5,224 +75	+1%	+$6.32K	0.08%	248
2022 Q2	$382K	Buy	+5,149	New	+$387K	0.07%	265
2021 Q3	–	Sell	-1,568	Closed	-$212K	–	453
2021 Q2	$212K	Sell	1,568 -25	-2%	-$3.29K	0.05%	399
2021 Q1	$216K	Sell	1,593 -50	-3%	-$7.49K	0.06%	365
2020 Q4	$231K	Buy	+1,643	New	+$210K	0.07%	337

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Wealth Alliance's XBI Position: Q2 2026 in Review

Wealth Alliance increased its State Street SPDR S&P Biotech ETF (XBI) stake by 2.8% in Q2 2026, buying an estimated $10.3K and bringing the position to 2,786 shares worth $441K. The position accounts for 0.04% of the portfolio, ranked #344.

Wealth Alliance first reported a position in XBI in Q4 2020 and has held it in 20 quarters since. The position peaked at $452K in Q4 2022. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Wealth Alliance held 2,786 shares of State Street SPDR S&P Biotech ETF worth $441K as of Q2 2026.
Wealth Alliance bought 76 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $10.3K.
State Street SPDR S&P Biotech ETF made up 0.04% of Wealth Alliance's portfolio in Q2 2026, its #344 holding.
Wealth Alliance first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 20 quarters since.
Wealth Alliance's State Street SPDR S&P Biotech ETF position peaked at $452K in Q4 2022.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Wealth Alliance's 13F filing for Q2 2026, filed 11 Aug 2026.